newsfilter
← Latest News
FDA Approved Drugs·

Approval of Elahere, Bla #761310

Approval Date: 07/14/2025; Drug Name: Elahere, Bla #761310; Active Ingredients: MIRVETUXIMAB SORAVTANSINE-GYNX; Company: Immunogen Inc; Submission Status: Approval; Application Number: 761310

Company
IMMUNOGEN INC
Keywords
IMMUNOGEN INC